Pfizer to Cash In on Cardiovascular Treatments as Heart Attack Deaths Skyrocket
Pharmaceutical giant Pfizer is set to cash in on new cardiovascular treatments as heart failure cases and related deaths skyrocket around the world. Pfizer is now expanding into medications for heart inflammation by gaining dominant control of the cardiovascular treatments market. The company has completed its purchase of Arena Pharmaceuticals for $6.7 billion. Arena Pharma … Read more